Literature DB >> 22593636

Lupus: an overview of the disease and management options.

William Maidhof, Olga Hilas.   

Abstract

Lupus is a chronic inflammatory autoimmune disease with a wide range of clinical presentations resulting from its effect on multiple organ systems. There are four main types of lupus: neonatal, discoid, drug-induced, and systemic lupus erythematosus (SLE), the type that affects the majority of patients. Patients with lupus experience a loss of self-tolerance as a result of abnormal immunological function and the production of autoantibodies, which lead to the formation of immune complexes that may adversely affect healthy tissue.Although the precise etiologic mechanism is unknown, genetic, hormonal, and environmental factors, as well as immune abnormalities, have been identified. Associations between lupus onset and age, sex, geography, and race have also been established. Management of this disease should be individualized and should include both pharmacological and nonpharmacological modalities for symptom relief and resolution as well as improved quality of life.

Entities:  

Year:  2012        PMID: 22593636      PMCID: PMC3351863     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  87 in total

Review 1.  Drug-induced rheumatic syndromes.

Authors:  Beth L Brogan; Nancy J Olsen
Journal:  Curr Opin Rheumatol       Date:  2003-01       Impact factor: 5.006

2.  Predictors of survival in systemic lupus erythematosus.

Authors:  Nuntana Kasitanon; Laurence S Magder; Michelle Petri
Journal:  Medicine (Baltimore)       Date:  2006-05       Impact factor: 1.889

3.  Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis.

Authors:  C T Ravirajan; M A Rahman; L Papadaki; M H Griffiths; J Kalsi; A C Martin; M R Ehrenstein; D S Latchman; D A Isenberg
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

4.  The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1985-01

Review 5.  Mechanism and regulation of immunoglobulin isotype switching.

Authors:  R L Coffman; D A Lebman; P Rothman
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

6.  Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus.

Authors:  C Speirs; A H Fielder; H Chapel; N J Davey; J R Batchelor
Journal:  Lancet       Date:  1989-04-29       Impact factor: 79.321

7.  Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block.

Authors:  Peter M Izmirly; Carolina Llanos; Lela A Lee; Anca Askanase; Mimi Y Kim; Jill P Buyon
Journal:  Arthritis Rheum       Date:  2010-04

8.  Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block.

Authors:  Robert M Clancy; Raj P Kapur; Yair Molad; Anca Dinu Askanase; Jill P Buyon
Journal:  Arthritis Rheum       Date:  2004-01

9.  Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.

Authors:  Karen H Costenbader; Diane Feskanich; Meir J Stampfer; Elizabeth W Karlson
Journal:  Arthritis Rheum       Date:  2007-04

10.  EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Authors:  G Bertsias; J P A Ioannidis; J Boletis; S Bombardieri; R Cervera; C Dostal; J Font; I M Gilboe; F Houssiau; T Huizinga; D Isenberg; C G M Kallenberg; M Khamashta; J C Piette; M Schneider; J Smolen; G Sturfelt; A Tincani; R van Vollenhoven; C Gordon; D T Boumpas
Journal:  Ann Rheum Dis       Date:  2007-05-15       Impact factor: 19.103

View more
  29 in total

1.  Systemic Lupus Erythematosus Presenting as Optic Neuropathy: A Case Report.

Authors:  Salman Zahid; Mustafa Iqbal
Journal:  Cureus       Date:  2019-06-03

2.  Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Nipith Charoenngam; Ben Ponvilawan; Wasit Wongtrakul; Patompong Ungprasert
Journal:  Clin Rheumatol       Date:  2020-07-07       Impact factor: 2.980

3.  No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.

Authors:  Zahra Rezaieyazdi; Samira Tabaei; Yalda Ravanshad; Javad Akhtari; Hassan Mehrad-Majd
Journal:  Clin Rheumatol       Date:  2018-01-02       Impact factor: 2.980

Review 4.  The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis.

Authors:  Michael Garshick; James A Underberg
Journal:  Curr Atheroscler Rep       Date:  2017-10-17       Impact factor: 5.113

5.  Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.

Authors:  Diane L Kamen; Caroline Wallace; Zihai Li; Megan Wyatt; Crystal Paulos; Chungwen Wei; Hongjun Wang; Bethany J Wolf; Paul J Nietert; Gary Gilkeson
Journal:  Lupus Sci Med       Date:  2022-07

Review 6.  CD11b agonists offer a novel approach for treating lupus nephritis.

Authors:  Veronica Villanueva; Xiaobo Li; Viviana Jimenez; Hafeez M Faridi; Vineet Gupta
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

Review 7.  Possible evidence of systemic lupus erythematosus and periodontal disease association mediated by Toll-like receptors 2 and 4.

Authors:  C P C Marques; Y Maor; M S de Andrade; V P Rodrigues; B B Benatti
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 8.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

9.  Outcomes of rituximab therapy in refractory lupus: A meta-analysis.

Authors:  Fatma Alshaiki; Elaf Obaid; Abdulqader Almuallim; Rabab Taha; Hadeel El-Haddad; Hani Almoallim
Journal:  Eur J Rheumatol       Date:  2018-02-13

Review 10.  The significant impact of apigenin on different aspects of autoimmune disease.

Authors:  Neda Kasiri; Mahshid Rahmati; Leila Ahmadi; Nahid Eskandari
Journal:  Inflammopharmacology       Date:  2018-09-18       Impact factor: 5.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.